EMMA MIDDLETON: Open Payments
NPI 1932679875 · DOTHAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,246 in 115 payments from 20 companies in 2025. Trend: 2023 $1,301 · 2024 $1,671 · 2025 $2,246
Food & beverage: $2,227Education: $19
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 22 | $632 |
| AstraZeneca Pharmaceuticals LP | 12 | $222 |
| ABBVIE INC. | 14 | $211 |
| Lilly USA, LLC | 15 | $201 |
| GlaxoSmithKline, LLC. | 13 | $192 |
| Janssen Pharmaceuticals, Inc | 1 | $125 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $115 |
| Merck Sharp & Dohme LLC | 7 | $101 |
| Amgen Inc. | 4 | $61 |
| Exact Sciences Corporation | 3 | $54 |
Products named: Wegovy, MOUNJARO, Ozempic, SPRAVATO, Kerendia, QULIPTA, TRELEGY ELLIPTA, VERQUVO.
Industry payments across AL — which companies pay providers there.
